IIM
CYTK icon

Ironwood Investment Management’s Cytokinetics CYTK Stock Holding History

Ironwood Investment Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Sell
56,738
-491
-0.9% -$31.2K 1.56% 11
2025
Q4 		$3.64M Sell
57,229
-103
-0.2% -$6.41K 1.53% 14
2025
Q3 		$3.15M Sell
57,332
-184
-0.3% -$7.58K 1.37% 17
2025
Q2 		$1.9M Sell
57,516
-2,325
-4% -$80.9K 0.92% 28
2025
Q1 		$2.41M Buy
59,841
+756
+1% +$34.7K 1.31% 17
2024
Q4 		$2.78M Sell
59,085
-460
-0.8% -$23.9K 1.38% 16
2024
Q3 		$3.14M Sell
59,545
-300
-0.5% -$16.7K 1.53% 11
2024
Q2 		$3.24M Buy
59,845
+71
+0.1% +$4.29K 1.73% 9
2024
Q1 		$4.19M Sell
59,774
-1,855
-3% -$143K 2.05% 8
2023
Q4 		$5.15M Sell
61,629
-473
-0.8% -$17.1K 2.7% 6
2023
Q3 		$1.83M Sell
62,102
-1,459
-2% -$48.6K 1.12% 25
2023
Q2 		$2.07M Sell
63,561
-415
-0.6% -$15.4K 1.19% 22
2023
Q1 		$2.25M Sell
63,976
-1,991
-3% -$81.2K 1.41% 16
2022
Q4 		$3.02M Sell
65,967
-1,892
-3% -$81.4K 1.99% 9
2022
Q3 		$3.29M Sell
67,859
-203
-0.3% -$9.77K 2.3% 5
2022
Q2 		$2.67M Sell
68,062
-900
-1% -$36.2K 1.79% 10
2022
Q1 		$2.54M Sell
68,962
-97
-0.1% -$3.45K 1.38% 16
2021
Q4 		$3.15M Buy
69,059
+1,096
+2% +$42.3K 1.56% 12
2021
Q3 		$2.43M Sell
67,963
-277
-0.4% -$8.15K 1.26% 18
2021
Q2 		$1.35M Sell
68,240
-948
-1% -$22.3K 0.68% 44
2021
Q1 		$1.61M Sell
69,188
-667
-1% -$14.2K 0.85% 27
2020
Q4 		$1.45M Sell
69,855
-1,269
-2% -$23.2K 0.85% 33
2020
Q3 		$1.54M Sell
71,124
-85
-0.1% -$1.99K 1.1% 21
2020
Q2 		$1.68M Sell
71,209
-341
-0.5% -$6.39K 1.31% 15
2020
Q1 		$844K Buy
71,550
+17,334
+32% +$221K 0.84% 38
2019
Q4 		$575K Sell
54,216
-2,226
-4% -$22.9K 0.4% 92
2019
Q3 		$642K Sell
56,442
-157
-0.3% -$1.97K 0.48% 77
2019
Q2 		$637K Sell
56,599
-10,753
-16% -$104K 0.5% 76
2019
Q1 		$545K Sell
67,352
-23,431
-26% -$172K 0.44% 86
2018
Q4 		$574K Sell
90,783
-10,308
-10% -$75.6K 0.53% 70
2018
Q3 		$996K Sell
101,091
-3,005
-3% -$24.1K 0.7% 45
2018
Q2 		$864K Sell
104,096
-1,228
-1% -$10.2K 0.61% 54
2018
Q1 		$758K Sell
105,324
-1,815
-2% -$15.6K 0.55% 62
2017
Q4 		$873K Sell
107,139
-3,373
-3% -$38.3K 0.62% 53
2017
Q3 		$1.6M Sell
110,512
-3,750
-3% -$51.2K 1.13% 22
2017
Q2 		$1.38M Sell
114,262
-3,840
-3% -$53.4K 1% 27
2017
Q1 		$1.52M Sell
118,102
-3,258
-3% -$38.1K 1.14% 21
2016
Q4 		$1.48M Sell
121,360
-12,149
-9% -$129K 1.08% 22
2016
Q3 		$1.23M Sell
133,509
-17,597
-12% -$184K 0.94% 32
2016
Q2 		$1.43M Sell
151,106
-23,199
-13% -$190K 1.07% 26
2016
Q1 		$1.23M Sell
174,305
-75,700
-30% -$553K 0.81% 46
2015
Q4 		$2.62M Sell
250,005
-91,111
-27% -$894K 1.08% 33
2015
Q3 		$2.28M Sell
341,116
-94,086
-22% -$642K 0.84% 53
2015
Q2 		$2.92M Sell
435,202
-175,731
-29% -$1.15M 0.67% 65
2015
Q1 		$4.14M Buy
610,933
+13,614
+2% +$102K 0.77% 56
2014
Q4 		$4.79M Buy
597,319
+736
+0.1% +$3.16K 0.87% 55
2014
Q3 		$2.1M Buy
596,583
+38,047
+7% +$160K 0.38% 79
2014
Q2 		$2.67M Buy
558,536
+15,514
+3% +$94.7K 0.43% 79
2014
Q1 		$5.16M Sell
543,022
-6,404
-1% -$57.9K 0.75% 62
2013
Q4 		$3.57M Buy
549,426
+51,414
+10% +$338K 0.5% 76
2013
Q3 		$3.77M Buy
498,012
+229,884
+86% +$2.47M 0.59% 70
2013
Q2 		$3.1M Buy
+268,128
New +$2.11M 0.55% 74

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ironwood Investment Management's CYTK Position: Q1 2026 in Review

Ironwood Investment Management reduced its Cytokinetics (CYTK) stake by 0.86% in Q1 2026, selling an estimated $31.2K and leaving 56,738 shares worth $3.74M. The position accounts for 1.56% of the portfolio, ranked #11.

Ironwood Investment Management first reported a position in CYTK in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.16M in Q1 2014. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Ironwood Investment Management held 56,738 shares of Cytokinetics worth $3.74M as of Q1 2026.
  • Ironwood Investment Management sold 491 Cytokinetics shares in Q1 2026, an estimated $31.2K.
  • Cytokinetics made up 1.56% of Ironwood Investment Management's portfolio in Q1 2026, its #11 holding.
  • Ironwood Investment Management first reported a position in Cytokinetics in Q2 2013 and has held it in 52 quarters since.
  • Ironwood Investment Management's Cytokinetics position peaked at $5.16M in Q1 2014.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Ironwood Investment Management's 13F filing for Q1 2026, filed 15 May 2026.